Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile by unknown
RESEARCH Open Access
Special low protein foods for
phenylketonuria: availability in Europe and
an examination of their nutritional profile
Maria João Pena1, Manuela Ferreira Almeida1,2, Esther van Dam3, Kirsten Ahring4, Amaya Bélanger-Quintana5,
Katharina Dokoupil6, Hulya Gokmen-Ozel7, Anna Maria Lammardo8, Anita MacDonald9, Martine Robert10
and Júlio César Rocha1,11,12*
Abstract
Background: Special low protein foods (SLPF) are essential in the nutritional management of patients with
phenylketonuria (PKU). The study objectives were to: 1) identify the number of SLPF available for use in eight
European countries and Turkey and 2) analyse the nutritional composition of SLPF available in one of these
countries.
Methods: European Nutritionist Expert Panel on PKU (ENEP) members (Portugal, Spain, Belgium, Italy, Germany,
Netherlands, UK, Denmark and Turkey) provided data on SPLF available in each country. The nutritional
composition of Portuguese SLPF was compared with regular food products.
Results: The number of different SLPF available in each country varied widely with a median of 107 [ranging from
73 (Portugal) and 256 (Italy)]. Food analysis of SLPF available from a single country (Portugal) indicated that the
mean phenylalanine content was higher in low protein baby cereals (mean 48 mg/100 g) and chocolate/energy
bars/jelly (mean 41 mg/100 g). The energy content of different foods from a sub-group of SLPF (cookies) varied
widely between 23 and 96 kcal/cookie. Low protein bread had a high fat content [mean 5.8 g/100 g (range 3.7 to
10)] compared with 1.6 g/100 g in regular bread. Seven of the 12 SLPF sub-groups (58 %) did not declare any
vitamin content, and only 4 (33 %) identified a limited number of minerals.
Conclusions: Whilst equal and free access to all SLPF is desirable, the widely variable nutritional composition
requires careful nutritional knowledge of all products when prescribed for individual patients with PKU. There is a
need for more specific nutritional standards for special low protein foods.
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Background
Early diagnosis and treatment of patients with phenylke-
tonuria (PKU) prevents major neuro-cognitive deficits
[1]. This is mainly achieved through the prescription of
a phenylalanine (Phe) restrictive diet, consisting of nat-
ural protein and Phe restriction, together with L-amino
acids supplements and special low protein foods (SLPF)
[2]; the latter also used in other inborn errors of amino
acid metabolism. The function of SLPF in the PKU diet
is to provide energy and variety in the diet [2]. In PKU
much emphasis has been placed on the role and dose of
L-amino acids but little attention is given to the nutri-
tional or energy profile of SLPF [3]. It is estimated that
the patient’s SLPF intake will depend on disorder sever-
ity, providing around 50 % of the total energy intake in
the most severe forms of the disorder. Milder pheno-
types, with a higher natural protein tolerance are likely
to be less dependent on their use [3].
SLPF have a low protein and Phe content but their
micronutrient composition is unclear. In a normal diet,
healthy energy food sources commonly provide other
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macro and micronutrients. In direct contrast, SLPF
micronutrient fortification is uncommon and it is as-
sumed that the majority of vitamins and minerals are
provided from L-amino acids supplemented with micro-
nutrients [4, 5].
SLPF are regulated by the European legislation ‘Foods
for Special Medical Purposes’ (Commission Directive
1999/21/EC of 25 March 1999; amended in Directive
2006/141/EC). This Directive sets out rules for the com-
position and labeling of foods that are specifically for-
mulated, processed and intended for the dietary
management of diseases, disorders or medical conditions
of individuals who are being treated under medical
supervision. The nutritional substances that may be used
in the manufacture of foods for special medical purposes
are also outlined in legislation: Commission Regulation
(EC) No 953/2009 [6]. In addition, all Foods for Special
Medical Purposes have to follow the European Food In-
formation to Consumers Regulation No 1169/2011 and
Regulation No 609/2013 which is only just being
enforced in many countries. Manufacturers must pro-
vide information concerning the energy value and prin-
cipal nutrients contained in such foods but only have to
declare the vitamins and/or minerals if they are present
in “significant amounts”.
The objectives of this study were to identify the num-
ber of SLPF accessible for use in eight European coun-
tries and Turkey and to study the differences in the
nutritional composition of SLPF available in one country
(Portugal).
Methods
In July 2014, comprehensive nutritional composition
data of SLPF suitable for PKU and available in Portugal
was collected from dietary companies or from SLPF
packaging labels. Excel product nutritional composition
databases with the numbers and types of SLPF were
created.
Products were organized in sub-groups: baby cereals,
bread, breakfast cereals, cakes/mix cakes/pancake mix,
chocolate/energy bars/jelly, cookies, flour, ice cream,
milk replacers, pasta, rice and savoury foods. Nutritional
composition was expressed in weight of product per
100 g or 100 mL. Vitamin and mineral profiles were
compared with regular foods, matched for food type.
Their nutritional composition was obtained from the
Portuguese Food Composition Table (available at
www.insa.pt) (exception was the micronutrient compos-
ition of regular baby cereals which was collected from
respective food companies).
Participants from the European Nutritionist Expert
Panel on PKU (ENEP) [a group of dietitians/medical
doctors from PKU centers in Europe (Portugal, Spain,
Belgium, Italy, Germany, Netherlands, UK, Denmark)
and Turkey] were invited to provide a list of SLPF avail-
able in their countries.
Results
Number of SLPF available in Europe and Turkey
In Italy there were over twice as many SLPF (n = 256)
available compared with other countries, although in 4
countries (Spain, Netherlands, Turkey and Denmark)
(Table 1) the exact number of products available was un-
known. Portugal had the least number of SLPF (n = 73)
(Table 1).
Nutritional composition of Portuguese SLPF
All Portuguese SLPF contained a mean Phe content
of less than 50 mg/100 g [mean 21 mg (6 mg in milk
replacers; 48 mg in baby cereals)], which is an accept-
able level for a SLPF for PKU (Table 2). Energy con-
tent varied widely between different SLPF sub-groups
(Table 2). The majority of SLPF sub-groups (with the
exception of milk replacers) contained energy content
ranging from 305 to 478 Kcal/100 g of product. Milk
replacers had a mean energy content of 99 kcal/
200 mL, whereas cookies contained a mean energy
content of 51 kcal per 11 g unit. For 14 different
cookies available in Portugal, the energy content var-
ied between 23 and 96 kcal per unit. The SLPF en-
ergy content was predominantly from carbohydrate
(CHO) and fat sources. SLPF with higher fat content
had the highest energy content (Table 2).
Within the SLPF sub-group of bread, the mean fat
content was 5.8 g/100 g with two products containing
almost 10 g/100 g, which is in contrast with the content
usually found in regular bread [1.6 g/100 g (Table 3)].
The energy contribution from CHO was also consider-
ably higher. The CHO content of SLPF cookies was
higher compared with regular cookies (Table 3).
Information regarding age suitability of SLPF was not
available on packaging for all products, although the ma-
jority contained this information. In general, SLPF food
labels provided unclear information about fat and CHO
quality/sources. The micronutrient composition of SLPF
was lower compared with regular-matched foods in
terms of vitamin and mineral profiles (Tables 4 and 5).
Considering all the 73 Portuguese SLPF analysed, 50
(69 %) of them stated only the mineral content on the
label, 16 (22 %) of them gave no information about the
vitamin and mineral profile and just 7 (10 %) products
Table 1 Number of different SLPF available in each country
Product PT SP BE IT GER NL TK UK DK
SLPF 73 NI 92 256 94 NI NI 121 NI
PT = Portugal; SP = Spain; BE = Belgium; IT = Italy; GER = Germany; NL =
Netherlands; TK = Turkey; UK = United Kingdom; DK = Denmark; SLPF = Special
low protein foods; NI = no information
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described the presence of vitamin and minerals on the
label. In 7 of 12 SLPF sub-groups (58 %) the presence of
any vitamin was not labelled on the packaging. For min-
erals, labelling was more common and in 8 of the 12
SLPF sub-groups (67 %), 100 % of the food items identi-
fied minerals on the food labelling.
Discussion
In PKU, a varying choice and availability of SLPF may
disadvantage some European patients in their ability to
achieve acceptable metabolic control. It was clear from
this study, that there was no uniform availability of SLPF
in eight European countries and Turkey, and in some
countries there was limited knowledge and central
‘control’ about the range and type of products available.
Different government policies and reimbursement strat-
egies clearly contribute to this disparity [7–9].
A higher availability of SLPF is considered a pivotal
part of a Phe-restricted diet. While their ingestion satis-
fies energy needs, they also help support “free” amino
acids anabolism, improve dietary adherence and thereby
help maintain blood Phe control within target ranges
[4]. More investigation is needed in order to understand
if availability of a higher and wider range of SLPF opti-
mizes dietary adherence and contributes to improved
nutritional status [10].
The energy content of all SLPF is important and
clearly justifies special attention when prescribing to
Table 2 Nutritional composition of SLPF available in Portugal, according to sub-groups
SLPF Usual portion Phe (mg) Protein (g) Fat (g) CHO (g) Energy (Kcal)
Baby Cereals 30 g 48 [4–70] 1.3 [0.2–1.8] 10.0 [0.5–14.8] 83.0 [77.1–95.0] 415 [381–449]
Bread 50 g 29 [10–65] 0.8 [0.5–1.3] 5.8 [3.7–10.0] 61.3 [50.0–82.3] 305 [236–412]
Breakfast Cereals 30 g 13 [5–31] 0.5 [0.2–1.0] 1.1 [0.7–1.9] 92.2 [90.5–93.6] 381 [370–387]
Cakes/Mix Cakes/Pancake Mix 50 g 11 [4–30] 0.4 [0.2–0.9] 5.2 [0.2–15.2] 77.6 [58.0–88.2] 362 [341–372]
Chocolate/Energy Bars/Jelly unit 41 [10–90] 1.2 [0.2–2.5] 18.5 [1.0–33.6] 67.6 [42.6–93.3] 441 [377–548]
Cookies unit 14 [2–34] 0.4 [0.1–0.8] 19.1 [1.5–49.4] 75.1 [48.3–87.7] 478 [395–639]
Flour variable 13 [10–15] 0.3 [0.3–0.4] 0.8 [0.4–1.1] 86.6 [82.8–89.6] 357 [344–372]
Ice Cream unit 27 [14–43] 0.7 [0.3–1.1] 4.5 [3.3–5.2] 85.6 [82.0–88.9] 386 [376–394]
Milk replacers 200 mL 6 [0.0–10] 0.2 [0.0–0.4] 2.7 [2.0–3.8] 6.1 [4.8–8.1] 49 [40–66]
Pasta 40 g 12 [11–13] 0.4 [0.2–0.5] 0.8 [0.6–1.2] 86.2 [85.4–87.4] 355 [348–363]
Rice 40 g 13 0.4 0.8 88.9 365
Savoury Foods unit 26 [0–90] 0.7 [0.0–2.1] 16.2 [0.0–39.5] 40.5 [0.0–88.4] 323 [0–577]
CHO = Carbohydrate; Phe = Phenylalanine; SLPF = Special low protein foods
Nutritional composition data is presented in mean [range] per 100 g / 100 mL of each SLPF sub-group
Table 3 Macronutrient and energy content of SLPF and regular foods available in Portugal
SLPF/regular
foods
Protein (g) Fat (g) CHO (g) Energy (Kcal)
SLPF Regular foods SLPF Regular foods SLPF Regular foods SLPF Regular foods
Baby Cereals 1.3 [0.2–1.8] 9.7 [5.9–16.5] 10.0 [0.5–14.8] 3.4 [1.1–7.8] 83.0 [77.1–95.0] 59.0 [66.8–89.4] 415 [381–449] 397 [393–403]
Bread 0.8 [0.5–1.3] 7.7 [5.3–11.2] 5.8 [3.7–10.0] 1.6 [0.8–2.3] 61.3 [50.0–82.3] 55.6 [37.2–71.6] 305 [236–412] 274 [185–360]
Breakfast Cereals 0.5 [0.2–1.0] 13.8 [13.5–14.0] 1.1 [0.7–1.9] 4.2 [2.5–5.8] 92.2 [90.5–93.6] 65.4 [61.7–69.0] 381 [370–387] 360 [360–360]
Cakes/Mix Cakes/
Pancake Mix
0.4 [0.2–0.9] 5.8 [4.2–7.4] 5.2 [0.2–15.2] 28.7 [26.4–31.0] 77.6 [58.0–88.2] 42.4 [37.8–47.0] 362 [341–372] 451 [445–456]
Chocolate/Energy
Bars/Jelly
1.2 [0.2–2.5] 47.5 [8.0–87.0] 18.5 [1.0–33.6] 17.0 [0.1–33.9] 67.6 [42.6–93.3] 26.6 [0.0–53.1] 441 [377–548] 448 [349–546]
Cookies 0.4 [0.1–0.8] 9.1 [7.3–10.8] 19.1 [1.5–49.4] 15.2 [12.2–17.8] 75.1 [48.3–87.7] 65.8 [61.0–72.0] 478 [395–639] 442 [436–451]
Flour 0.3 [0.3–0.4] 8.4 [7.8–9.0] 0.8 [0.4–1.1] 1.2 [1.1–1.3] 86.6 [82.8–89.6] 75.2 [74.3–76.0] 357 [344–372] 354 [347–361]
Ice Cream 0.7 [0.3–1.1] 2.0 [0.4–3.6] 4.5 [3.3–5.2] 5.5 [0.0–10.9] 85.6 [82.0–88.9] 27.2 [21.7–32.6] 386 [376–394] 164 [130–198]
Milk replacers 0.2 [0.0–0.4] 3.4 [3.3–3.4] 2.7 [2.0–3.8] 0.9 [0.2–1.6] 6.1 [4.8–8.1] 9.8 [4.9–4.9] 49 [40–66] 41 [34–47]
Pasta 0.4 [0.2–0.5] 13.2 [12.4–13.9] 0.8 [0.6–1.2] 2.5 [1.8–3.1] 86.2 [85.4–87.4] 68.8 [67.6–70.0] 355 [348–363] 358 [354–361]
Rice 0.4 6.7 0.8 0.4 88.9 78.1 365 352
Savoury Foods 0.7 [0.0–2.1] 25.1 [20.2–30.0] 16.2 [0.0–39.5] 10.4 [6.8–14.0] 40.5 [0.0–88.4] 0.1 [0.0–0.2] 323 [0–577] 195 [142–247]
CHO = Carbohydrate; SLPF = Special low protein foods
Nutritional composition data is presented in mean [range] per 100 g / 100 mL of each SLPF sub-group and corresponding regular Portuguese foods
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patients in different clinical situations. In our opinion,
the results presented here clearly justify improved label-
ling that would lead to better food choices. Considering
the recent interest of nutritional status in the PKU man-
agement, other aspects of nutrition should be considered
beyond blood Phe control [11]. Although similar to the
general population, overweight is a concern in PKU, es-
pecially in older females [3] with poor Phe control. Diet-
ary intake also clearly influences cardiometabolic
markers and more detailed research is needed to under-
stand if differences found between patients and controls
have some origin in different dietary patterns [12]. When
lipid and CHO compositions were compared with regu-
lar foods, we found higher contributions in 58 and 92 %
of SLPF subgroups, respectively. These data, together
with the fact that in 75 % of the SLPF sub-groups the
energy content was higher than in regular foods, under-
lines the need for careful nutritional prescription and
monitoring.
Another common feature of SLPF is lack of label
micronutrient information when compared with regular
matched-foods. Although micronutrients are mainly
consumed through L-amino acid supplements [13, 14],
it is important that the nutritional profile is fully identi-
fied on the label. Also SLPF should contain a warning
indicating that their nutritional profile does not replicate
regular foods because patients, caregivers and health
professionals may assume they provide other nutrients
other than energy. At present, there are no detailed
studies outlining their full nutritional contribution to a
low Phe diet.
PKU is a chronic disorder and regular nutritional edu-
cation is required [15]. It is essential that health profes-
sionals provide guidance on the amount of SLPF that
should be prescribed in different clinical situations in
PKU (e.g. children, pregnancy, overweight/obesity, with
and without Sapropterin treatment). In order to
optimize dietary prescription and to prevent nutritional
status imbalances like overweight/obesity, the Portu-
guese PKU center adopted a color system in order to
categorize SLPF, based on its nutritional profile. This
analogy with the traffic light colors has been adopted on
Table 4 Vitamin profile of SLPF sub-groups in comparison with regular-matched foods available in Portugal
SLPF Regular-matched foods
Food item (N) % of foods with vitamin
content identified on food label
Vitamins Food item (N) % of foods with vitamin




50 % A, D, E, K, C, B1,




100 % A, D, E, K, C, B1,
B2, B3, B5, B6,
B9, B12.
Bread (n = 9) 0 % * Bread (n = 4) 100 % E, B1, B2, B3,
B6, B9.
Breakfast
Cereals (n = 4)
50 % A, D, E, K, C, B1,
B2, B3, B5, B6,
B9, B12. *




Mix (n = 6)
0 % * Cakes/Mix Cakes/Pancake Mix
(n = 2)
100 % A, D, E, B1, B2,
B3, B6, B9, B12.
Chocolate/
Energy Bars/
Jelly (n = 5)
20 % E, B1. * Chocolate/Energy Bars/Jelly
(n = 2)




7 % B1, B2, B3, B6. * Cookies (n = 4) 100 % E, B1, B2, B3,
B6, B9.




0 % * Ice Cream (n = 2) 50 % A, D, E, C, B1,




0 % * Milk (n = 2) 100 % A, D, E, B1, B2,
B3, B6, B9, B12.
Pasta (n = 13) 0 % * Pasta (n = 2) 100 % D, E, B1, B2, B3,
B6, B9.




0 % * Savoury Foods (n = 2) 100 % D, E, B1, B2, B3,
B6, B9, B12.
*All other products/All products either have nil content or no information in label
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regular food labeling in order to keep the consumer
alerts about the nutritional composition of food, mainly
in respect with fat (especially saturated fat), salt and
added sugars per 100 g (available at http://
www.food.gov.uk).
Conclusions
The difference found in the SLPF availability within Eur-
ope and Turkey is relevant and may contribute to differ-
ence in patient ability to maintain acceptable metabolic
control across Europe. It is important that industry ensure
a high quality of SLPF in respect to taste, acceptability and
appearance to help improve patient adherence with diet
therapy. However, it is also important that manufacturers
increase the detail about nutritional composition and
product labelling, although the European Food Informa-
tion to Consumers Regulation No 1169/2011 should help
improve the quality of information provided in the future.
A careful analysis of nutritional profile of all products is
desirable in order to better match the nutrient needs of
each patient.
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Table 5 Mineral profile of SLPF sub-groups in comparison with regular-matched foods available in Portugal
SLPF Regular-matched foods
Food item (N) % of foods with mineral content
identified on food label
Minerals Food item (N) % of foods with mineral content
identified on food label
Minerals
Baby Cereals (n = 4) 100 % Ca, Fe, Na, K,
Zn, Se, Cu.
Baby Cereals (n = 3) 100 % Ca, Fe, Na, K,
Zn, I.
Bread (n = 9) 44 % Ca, Na, K. * Bread (n = 4) 100 % Ca, Fe, Na, K,
P, Mg, Zn.
Breakfast Cereals (n =
4)
100 % Fe, Na, K. Breakfast Cereals (n =
2)
100 % Ca, Fe, Na, K,
P, Mg, Zn.
Cakes / Mix Cakes /
Pancake Mix (n = 6)
100 % Ca, Na, K. Cakes / Mix Cakes /
Pancake Mix (n = 2)
100 % Ca, Fe, Na, K,
P, Mg, Zn.
Chocolate / Energy
Bars / Jelly (n = 5)
100 % Ca, Na, K. Chocolate / Energy
Bars / Jelly (n = 2)
100 % Ca, Fe, Na, K,
P, Mg, Zn.
Cookies (n = 14) 86 % Ca, Fe, Na, K.
*
Cookies (n = 4) 100 % Ca, Fe, Na, K,
P, Mg, Zn.
Flour (n = 3) 100 % Na, K. Flour (n = 2) 100 % Ca, Fe, Na, K,
P, Mg, Zn.
Ice Cream (n = 3) 100 % Ca, Na, K. Ice Cream (n = 2) 100 % Ca, Fe, Na, K,
P, Mg, Zn.
Milk replacers (n = 4) 100 % Ca (in 50 %),
Na, K.
Milk (n = 2) 100 % Ca, Fe, Na, K,
P, Mg, Zn.
Pasta (n = 13) 23 % Na, K. * Pasta (n = 2) 100 % Ca, Fe, Na, K,
P, Mg, Zn.
Rice (n = 1) 100 % Na, K. Rice (n = 1) 100 % Ca, Fe, Na, K,
P, Mg, Zn.
Savoury Foods (n = 7) 71 % Ca, Fe, Na, K.
*
Savoury Foods (n = 2) 100 % Ca, Fe, Na, K,
P, Mg, Zn.
*All other products/All products either have nil content or no information in label
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